M1 Kliniken AG (M12.DE) • XETRA
Unlock comprehensive alternative data signals to make better investment decisions

Track website visits, page views, unique visitors, and engagement metrics over time to gauge online interest and brand strength.

Monitor Twitter follower growth, engagement rates, and social media presence to understand brand reach and community sentiment.

Analyze TikTok follower trends and viral content performance to measure youth demographic appeal and cultural relevance.

Track Facebook page likes, comments, shares, and post engagement to assess community interaction and brand loyalty.

Monitor Instagram follower growth, engagement rates, and visual content performance across demographics.

Track YouTube channel growth, video views, and subscriber engagement to measure content marketing effectiveness.

Monitor LinkedIn company page followers and professional network growth to assess B2B brand strength and talent attraction.

Track open job positions and hiring trends as a leading indicator of company expansion, contraction, or strategic shifts.

Monitor employee headcount changes on LinkedIn to gauge organizational growth, restructuring, or cost-cutting measures.

Analyze sentiment scores from Reddit discussions to understand retail investor mood and potential price momentum.

Track daily news mentions across major publications to measure media attention, PR effectiveness, and market awareness.

View key financial metrics including Revenue, Net Income, EPS, Free Cash Flow, EBITDA, and Total Assets. Access 2-year quarterly charts for Revenue & Income and Free Cash Flow trends.

Analyze technical indicators including 50-day Simple Moving Average (SMA) with price overlay and Relative Strength Index (RSI) charts.
TrendEdge provides tools and data for research and educational purposes only and does not provide investment advice or personal recommendations.
You don't hold M12.DE in your mock portfolio yet.
With EPS of €0.95 and a PE ratio of 17.05, M1 Kliniken AG appears reasonably valued relative to typical mid-cap healthcare/consumer names, suggesting neither clear overvaluation nor deep value. The positive earnings indicate underlying profitability, but without multi-period revenue and margin data, it is difficult to confirm a strong growth or margin expansion story.
The stock trading at €16.20, above its 200-day moving average of €15.56, combined with a 12.3% gain over the last month, suggests positive price momentum. Trading above the long-term moving average typically signals an uptrend, and the recent outperformance indicates improving investor sentiment.
Web traffic of roughly 13,073 visitors per month and stable-to-slightly-growing social media followings indicate a steady but not rapidly accelerating brand presence. The absence of job openings points to operational stability but may also imply limited near-term expansion initiatives.
Overall, M1 Kliniken AG presents a mixed picture: technically the stock is in an uptrend with solid recent price momentum, but fundamental and alternative data signals point more to stability than to strong acceleration. The valuation appears reasonable, and the business is profitable, yet the lack of clear growth signals in hiring and digital traction keeps the outlook balanced rather than strongly bullish.
Our AI Score rates companies on a scale from 0 to 10, based on alternative data points such as web traffic, app downloads, and job postings — combined with financial health indicators and technical signals.
Upgrade to see the full Evidence Stack
What Changed, Why Now, and Risk Flags — available on the Investor plan and above
Get Started